Syndax Pharmaceuticals Inc. (SNDX)
NASDAQ · Healthcare
Syndax Pharmaceuticals Inc. Total Liabilities 2015–2025
Syndax Pharmaceuticals Inc. annual total liabilities history from 2015 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Syndax Pharmaceuticals Inc. total liabilities as of December 31, 2025: 465.1M, a 6.50% increase year-over-year.
- Syndax Pharmaceuticals Inc. total liabilities for 2025 were 465.1M, a 6.50% increase from 2024.
- Syndax Pharmaceuticals Inc. total liabilities for 2024 were 436.7M, a 644.14% increase from 2023.
- Syndax Pharmaceuticals Inc. total liabilities for 2023 were 58.7M, a 97.01% increase from 2022.
- Syndax Pharmaceuticals Inc. total liabilities for 2022 were 29.8M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Syndax Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $465 |
| 2024 | $437 |
| 2023 | $59 |
| 2022 | $30 |
| 2021 | $41 |
| 2020 | $48 |
| 2019 | $32 |
| 2018 | $31 |
| 2017 | $33 |
| 2016 | $25 |
| 2015 | $23 |
Syndax Pharmaceuticals Inc. Total Liabilities — FAQ
Syndax Pharmaceuticals Inc. (SNDX) total liabilities over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SNDX's total liabilities history?
The chart and table above show Syndax Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.